Clinical Trial Update: Boron Neutron Capture Therapy (BNCT) as Treatment of Glioblastoma [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial of boron neutron capture therapy for glioblastoma has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Boron Neutron Capture Therapy (boron neutron capture therapy)

Snippet

Sponsor: Boneca Corporation | Conditions: Glioblastoma | Phase 1, Phase 2 | Status: TERMINATED